Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; Arauz, G.; Curley, T.; Tse, K.; Halabi, S.; Scher, H. I.; Kelly, W. K.
Abstract Title: Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 289s
Language: English
ACCESSION: WOS:000404711501069
DOI: 10.1200/JCO.2016.34.15_suppl.TPS5093
PROVIDER: wos
Notes: Meeting Abstract: TPS5093 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Lewis J Kampel
    19 Kampel
  2. Susan Slovin
    236 Slovin
  3. Michael Morris
    440 Morris
  4. William K Kelly
    115 Kelly
  5. Yu Chen
    104 Chen
  6. Karen Anne Autio
    98 Autio
  7. Ana Maria Luisa Molina
    50 Molina
  8. Gabrielle Arauz
    14 Arauz
  9. Howard Scher
    1081 Scher
  10. Kin   Tse
    6 Tse
  11. Emily Ann Carbone
    22 Carbone